As temperatures dropped, the number of patients with respiratory problems increased, leading to a shortage of environmental allergy vaccine at the National Institute of Health (NIH).
According to details surfaced on Wednesday, allergy centres have been reduced to providing only testing services, and hundreds of patients from across the country returned home without receiving the vaccine.
The National Health Institute required more than 600 doses of vaccine daily for patients arriving from various cities. Patients suffering from asthma, cold, flu, eye allergies, and respiratory or throat conditions remain deprived of the allergy vaccine.
The number of patients waiting for the allergy vaccine has reached four thousand. The cost of a single vaccine is 1,000. Dr Mohammad Salman, CEO of the National Health Institute, confirmed the shortage, saying that a chemical issue delayed the post-production stage of the vaccine. He assured that the remaining vaccines are available and that prompt availability of the allergy vaccine will be ensured.
